GENTILLY, France--(BUSINESS WIRE)--THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance ...

Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Read here for an analysis on two 11%+ yielding picks, which embody inflation-hedging and value-oriented factors.

S&P 500 stays resilient as Big Tech and AI CapEx drive growth. Economic indicators confirm a cyclical upswing. See more on ...

The fallout from the latest release has reverberated around the world, leading some people named in the files to resign.

Brothers and Sisters...the time has come for each and every one of you to decide whether you are going to be the problem or whether you are going to be the solution! You must choose Brothers, you must ...

Robert Duvall dies at 95 as Hollywood shifts, Qobuz fights AI music, Paramount takes Warner, and the industry braces for what comes next.